inclusion criteria: provide written, informed consent prior to all study-related procedures. provide written, informed consent to undergo human immunodeficiency virus (hiv) testing. willingness and ability to attend scheduled visits and undergo study assessments. able and willing to measure their oxygen saturation level and temperature, record their covid-19 symptoms and complete a patient diary. male or female aged 18 years or older. confirmed and documented sars-cov-2 infection, defined as rt-pcr laboratory confirmation. clinical and/or radiological findings indicative of moderate covid-19 disease

inclusion criteria: provide written, informed consent prior to all study-related procedures. provide written, informed consent to undergo human immunodeficiency virus (hiv) testing. willingness and ability to attend scheduled visits and undergo study assessments. able and willing to measure their oxygen saturation level and temperature, record their covid-19 symptoms and complete a patient diary. male or female aged 18 years or older. confirmed and documented sars-cov-2 infection, defined as rt-pcr laboratory confirmation. clinical and/or radiological findings indicative of moderate covid-19 disease

inclusion criteria: 1. provide written, informed consent prior to all study-related procedures. 2. provide written, informed consent to undergo human immunodeficiency virus (hiv) testing. 3. willingness and ability to attend scheduled visits and undergo study assessments. 4. able and willing to measure their oxygen saturation level and temperature, record their covid-19 symptoms and complete a patient diary. 5. male or female aged 18 years or older. 6. confirmed and documented sars-cov-2 infection, defined as rt-pcr laboratory confirmation. 7. clinical and/or radiological findings indicative of moderate covid-19 disease

inclusion criteria: 1. provide written, informed consent prior to all study-related procedures. 2. provide written, informed consent to undergo human immunodeficiency virus (hiv) testing. 3. willingness and ability to attend scheduled visits and undergo study assessments. 4. able and willing to measure their oxygen saturation level and temperature, record their covid-19 symptoms and complete a patient diary. 5. male or female aged 18 years or older. 6. confirmed and documented sars-cov-2 infection, defined as rt-pcr laboratory confirmation. 7. clinical and/or radiological findings indicative of moderate covid-19 disease

inclusion criteria: 1. provide written, informed consent prior to all study-related procedures. 2. provide written, informed consent to undergo human immunodeficiency virus (hiv) testing. 3. willingness and ability to attend scheduled visits and undergo study assessments. 4. able and willing to measure their oxygen saturation level and temperature, record their covid-19 symptoms and complete a patient diary. 5. male or female aged 18 years or older. 6. confirmed and documented sars-cov-2 infection, defined as rt-pcr laboratory confirmation. 9. clinical and/or radiological findings indicative of moderate covid-19 disease

inclusion criteria: 1. provide written, informed consent prior to all study-related procedures. 2. provide written, informed consent to undergo human immunodeficiency virus (hiv) testing. 3. willingness and ability to attend scheduled visits and undergo study assessments. 4. able and willing to measure their oxygen saturation level and temperature, record their covid-19 symptoms and complete a patient diary. 5. male or female aged 18 years or older. 6. confirmed and documented sars-cov-2 infection, defined as rt-pcr laboratory confirmation. 9. clinical and/or radiological findings indicative of moderate covid-19 disease